Octagon Capital Advisors LP Cytek Biosciences, Inc. Transaction History

Octagon Capital Advisors LP

  • $433 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$9.89 - $17.25 $3.96 Million - $6.9 Million
-400,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$16.14 - $25.04 $1.61 Million - $2.5 Million
-100,000 Reduced 20.0%
400,000 $6.53 Million
Q3 2021

Nov 15, 2021
BUY
$17.52 - $27.93 $8.76 Million - $14 Million
500,000 New
500,000 $10.7 Million

Others Institutions Holding CTKB

# of Institutions
135
Shares Held
73.9M
Call Options Held
200
Put Options Held
100
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $688M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email